Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing
Latus Bio
Press Releases
Showing 1–37 of 37
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm
Relation
Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology
Unlearn
Fervo Energy Raises $244 Million to Accelerate Deployment of Next-Generation Geothermal
Fervo Energy
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Freenome
TCarta and Capella Space Partner to Leverage All-weather SAR Imagery for Coastline Management
Capella Space
Fervo Energy Drilling Results Show Rapid Advancement of Geothermal Performance
Fervo Energy
U.S. DOE Approves the Safety Design Strategy for the Oklo Aurora Fuel Fabrication Facility
Oklo
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
Recursion Pharmaceuticals
Plexium Initiates Dosing in Phase 1 Study of PLX-4545, a Potent and Selective Degrader of the Transcription Factor IKZF2
Plexium
Planet Labs PBC Releases First Ground Testing Results for NASA CSP Program
Planet
Radiant to Partner with Idaho National Laboratory in $3.9M FEEED Program
Radiant Nuclear
Oklo Tentatively Selected to Provide Clean and Resilient Power to Eielson Air Force Base
Oklo
Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets
Solu Therapeutics
Top Sustainability VCs Lead $US28 Million Series B for Australian Breakthrough Mining Tech Plotlogic
Plotlogic
Proprio Raises $43M Series B Funding to Fuel Commercialization
Proprio
NASA Selects Zeno to Lead Team to Develop Radioisotope Power System for Lunar Applications
Zeno Power
Fervo Energy Announces Technology Breakthrough in Next-Generation Geothermal
Fervo Energy
Climate Breakthrough: Brimstone’s Decarbonized Portland Cement First to Meet Essential Building Industry Standard, Unlocking the Potential of Net-Zero Construction
Brimstone
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
Recursion Pharmaceuticals
Oklo, an Advanced Fission Technology Company, to Go Public via Merger with AltC Acquisition Corp.
Oklo
Twelve Commences Construction of First Commercial-Scale Plant in US for Producing Sustainable Aviation Fuel from CO2
Twelve
Databricks Signs Definitive Agreement to Acquire MosaicML, a Leading Generative AI Platform
Databricks
MosaicML
Kanvas Biosciences Announces $12 Million Pre-Series A to Accelerate Microbiome Drug Development
Kanvas Biosciences
Capella Space Awarded Multi-Year Blanket Purchase Agreement by NASA
Capella Space
Nium raises funds to replace Haber-Bosch, the most polluting chemical industrial process on Earth
Nium
Demox Labs Launches Leo Wallet and Raises $4.5 Million To Build Zero Knowledge Proof Blockchain Infrastructure
Demox Labs
Amogy, Skansi and SEAM Sign MoU to Explore Ammonia as Fuel for Offshore Supply Vessels
Amogy
Auradine Raises $81 Million in Series A Financing for Next-Generation Web Infrastructure
Auradine
Twelve and Etihad Airways partner to advance sustainable aviation fuel made from CO2 and renewable energy
Twelve
LiveEO and Capella Space Partner to bring High-Speed, High-Resolution SAR Satellite Insights to Asset Managers
Capella Space
MosaicML Launches Inference API and Foundation Series for Generative AI; Leading Open Source GPT Models, Enterprise-Grade Privacy and 15x Cost Savings
MosaicML
Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge
Ascend Advanced Therapies
First Light Field-Enabled Spine Surgery Navigation Platform, Proprio Paradigm™, Receives FDA Clearance
Proprio
Leading Venture Investors Form Global Alliance to Build Net Zero Businesses from Day Zero
Fervo Energy Announces Investment From US Oil And Gas Leader Devon Energy
Fervo Energy
Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors
Totus Medicines